Roche Inks Second Drug Discovery Deal With Jnana Therapeutics


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


  • Roche Holdings AG (OTC: RHHBY) has doubled down on a partnership with Jnana Therapeutics, paying $50 million upfront to tap its drug discovery platform across cancer, immune-mediated, and neurological diseases.
  • The collaboration allows Jnana to conduct discovery and preclinical activities against multiple cancer, immune-mediated and neurological disease targets, whereas Roche will develop and commercialize final products.
  • The new agreement has a potential deal value of around $2 billion. It comes two years after Roche paid $40 million upfront with $1 billion at the back end for a program targeting immune-mediated and neurological diseases.
  • Their earlier partnership, signed in 2020, covered small molecule drugs directed at SLC transporters, a class of more than 450 human membrane proteins that are gatekeepers for controlling the movement of metabolites in and out of cells and organs.
  • Alongside the deal, Jnana is also taking the wraps off a $107 million Series C that will fuel its internal efforts — particularly the lead program, an oral treatment for the rare metabolic disease phenylketonuria (PKU) currently in Phase 1.
  • Jnana said that the funding would allow it to take JNT-517 through proof-of-concept testing in PKU, a genetic disorder caused by an inability to break down the amino acid phenylalanine in the diet.
  • Price Action: RHHBY shares are up 0.65% at $41.54 on the last check Tuesday.

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: BiotechLarge CapNewsHealth CareContractsGeneralBriefs